Show simple item record

dc.contributor.advisorAlayev, Anyaen_US
dc.contributor.authorIsrael, Adina
dc.date.accessioned2019-07-08T19:40:28Z
dc.date.available2019-07-08T19:40:28Z
dc.date.issued2019-06-14
dc.identifier.citationIsrael, Adina. Breast Cancer: The Past, the Present, and a Look Towards the Future Presented to the S. Daniel Abraham Honors Program in Partial Fulfillment of the Requirements for Completion of the Program Stern College for Women Yeshiva University June 14, 2019.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12202/4480
dc.identifier.urihttps://yulib002.mc.yu.edu/login?url=https://repository.yu.edu/handle/20.500.12202/4480
dc.descriptionThe file is restricted for YU community access only.en_US
dc.description.abstractBreast cancer is a multifactorial and complicated disease with many risk factors, subcategories, and therapy options. The current methods of therapy cause great harm to the woman they are attempting to heal and their success in healing is inconsistent. Researchers disagree on which treatment options are most successful for each subclass of breast cancer. Tamoxifen, for example, is regarded by some as a highly successful therapy for estrogen-receptor positive breast cancers. Other researchers however, think Tamoxifen does more harm than it does good and should not be used. This is one of several similar controversies discussed in this thesis (other include whether estrogen should be upregulated or down-regulated, whether self and clinical breast screening are beneficial or dangerous etc.). The thesis will address the many opinions surrounding important decisions in breast cancer treatment and suggest that a more systemized method (genomic screening) should be used to determine when each treatment option will be successful and when it will be resisted. It will also suggest future success trends in breast cancer treatment, mainly the development of the immunotherapy treatment method which will reduce resistance and harsh side effects and promote successful healing in even the most challenging cases.en_US
dc.description.sponsorshipS. Daniel Abraham Honors Program of Stern College for Womenen_US
dc.language.isoen_USen_US
dc.publisherStern College for Women. Yeshiva University.en_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectbreast canceren_US
dc.subjectsenior honors thesisen_US
dc.subjectTamoxifenen_US
dc.subjecttherapiesen_US
dc.subjectestrogen-receptor positive breast canceren_US
dc.subjectbreast cancer treatmenten_US
dc.subjectimmunotherapy treatmenten_US
dc.subjectHER2 Positive breast canceren_US
dc.subjectHER2 Negative Breast Canceren_US
dc.subjectTrastuzumaben_US
dc.subjectLumpectomyen_US
dc.subjectMastectomyen_US
dc.subjectProphylactic Surgeryen_US
dc.subjectRadiation therapyen_US
dc.subjectChemotherapyen_US
dc.subjectCombination therapyen_US
dc.subjectProgesteroneen_US
dc.subjectepigeneticsen_US
dc.subjecthereditary factorsen_US
dc.subjectgenetic influencesen_US
dc.subjectclinical diagnosisen_US
dc.titleBreast Cancer: The Past, the Present, and a Look Towards the Future.en_US
dc.title.alternativePresented to the S. Daniel Abraham Honors Program in Partial Fulfillment of the Requirements for Completion of the Program.en_US
dc.typeThesisen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States